Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$43.93 - $46.76 $34.1 Million - $36.3 Million
-775,772 Reduced 45.49%
929,437 $41.9 Million
Q1 2023

May 15, 2023

SELL
$45.29 - $50.76 $15.1 Million - $16.9 Million
-332,500 Reduced 16.32%
1,705,209 $78.3 Million
Q4 2022

Feb 14, 2023

SELL
$41.91 - $50.48 $2.6 Million - $3.13 Million
-61,957 Reduced 2.95%
2,037,709 $102 Million
Q3 2022

Nov 14, 2022

SELL
$40.9 - $50.42 $3 Million - $3.7 Million
-73,345 Reduced 3.38%
2,099,666 $88.4 Million
Q2 2022

Aug 15, 2022

SELL
$42.98 - $49.77 $57.1 Million - $66.2 Million
-1,329,239 Reduced 37.95%
2,173,011 $102 Million
Q1 2022

May 16, 2022

SELL
$42.23 - $54.3 $3 Million - $3.86 Million
-71,016 Reduced 1.99%
3,502,250 $172 Million
Q4 2021

Feb 14, 2022

BUY
$50.62 - $56.47 $17.9 Million - $20 Million
354,596 Added 11.02%
3,573,266 $199 Million
Q3 2021

Nov 15, 2021

SELL
$46.55 - $56.83 $73 Million - $89.1 Million
-1,568,306 Reduced 32.76%
3,218,670 $167 Million
Q2 2021

Aug 16, 2021

SELL
$46.28 - $52.75 $159 Million - $181 Million
-3,428,146 Reduced 41.73%
4,786,976 $231 Million
Q1 2021

May 17, 2021

SELL
$46.25 - $56.02 $383 Million - $464 Million
-8,281,146 Reduced 50.2%
8,215,122 $398 Million
Q4 2020

Feb 16, 2021

SELL
$46.09 - $54.74 $81.9 Million - $97.3 Million
-1,777,739 Reduced 9.73%
16,496,268 $856 Million
Q3 2020

Nov 16, 2020

BUY
$42.51 - $52.42 $538 Million - $663 Million
12,652,105 Added 225.05%
18,274,007 $955 Million
Q2 2020

Aug 14, 2020

BUY
$39.49 - $44.36 $173 Million - $195 Million
4,386,217 Added 354.96%
5,621,902 $241 Million
Q1 2020

Aug 14, 2020

SELL
$33.17 - $41.6 $37.4 Million - $46.9 Million
-1,127,024 Reduced 47.7%
1,235,685 $50.7 Million
Q4 2019

Feb 14, 2020

BUY
$25.41 - $43.1 $60 Million - $102 Million
2,362,709 New
2,362,709 $79.9 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.2B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Davidson Kempner Capital Management LP Portfolio

Follow Davidson Kempner Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Kempner Capital Management LP with notifications on news.